These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 17425606

  • 1. The neuropeptide pituitary adenylate cyclase-activating polypeptide exerts anti-apoptotic and differentiating effects during neurogenesis: focus on cerebellar granule neurones and embryonic stem cells.
    Falluel-Morel A, Chafai M, Vaudry D, Basille M, Cazillis M, Aubert N, Louiset E, de Jouffrey S, Le Bigot JF, Fournier A, Gressens P, Rostène W, Vaudry H, Gonzalez BJ.
    J Neuroendocrinol; 2007 May; 19(5):321-7. PubMed ID: 17425606
    [Abstract] [Full Text] [Related]

  • 2. Altered cerebellar development in mice lacking pituitary adenylate cyclase-activating polypeptide.
    Allais A, Burel D, Isaac ER, Gray SL, Basille M, Ravni A, Sherwood NM, Vaudry H, Gonzalez BJ.
    Eur J Neurosci; 2007 May; 25(9):2604-18. PubMed ID: 17561835
    [Abstract] [Full Text] [Related]

  • 3. The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32.
    Vaudry D, Gonzalez BJ, Basille M, Pamantung TF, Fontaine M, Fournier A, Vaudry H.
    Proc Natl Acad Sci U S A; 2000 Nov 21; 97(24):13390-5. PubMed ID: 11087878
    [Abstract] [Full Text] [Related]

  • 4. Pituitary adenylate cyclase-activating polypeptide inhibits caspase-3 activity but does not protect cerebellar granule neurons against beta-amyloid (25-35)-induced apoptosis.
    Vaudry D, Cottet-Rousselle C, Basille M, Falluel-Morel A, Fournier A, Vaudry H, Gonzalez BJ.
    Regul Pept; 2004 Dec 15; 123(1-3):43-9. PubMed ID: 15518892
    [Abstract] [Full Text] [Related]

  • 5. Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death.
    Vaudry D, Rousselle C, Basille M, Falluel-Morel A, Pamantung TF, Fontaine M, Fournier A, Vaudry H, Gonzalez BJ.
    Proc Natl Acad Sci U S A; 2002 Apr 30; 99(9):6398-403. PubMed ID: 11972030
    [Abstract] [Full Text] [Related]

  • 6. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide promote the genesis of calcium currents in differentiating mouse embryonic stem cells.
    Chafai M, Basille M, Galas L, Rostene W, Gressens P, Vaudry H, Gonzalez BJ, Louiset E.
    Neuroscience; 2011 Dec 29; 199():103-15. PubMed ID: 22001490
    [Abstract] [Full Text] [Related]

  • 7. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
    Aubert N, Falluel-Morel A, Vaudry D, Xifro X, Rodriguez-Alvarez J, Fisch C, de Jouffrey S, Lebigot JF, Fournier A, Vaudry H, Gonzalez BJ.
    J Neurochem; 2006 Nov 29; 99(4):1237-50. PubMed ID: 17026529
    [Abstract] [Full Text] [Related]

  • 8. Pituitary adenylate cyclase-activating peptide (PACAP) induces differentiation in the neuronal F11 cell line through a PKA-dependent pathway.
    McIlvain HB, Baudy A, Sullivan K, Liu D, Pong K, Fennell M, Dunlop J.
    Brain Res; 2006 Mar 10; 1077(1):16-23. PubMed ID: 16487495
    [Abstract] [Full Text] [Related]

  • 9. Pituitary adenylate cyclase-activating polypeptide prevents C2-ceramide-induced apoptosis of cerebellar granule cells.
    Vaudry D, Falluel-Morel A, Basille M, Pamantung TF, Fontaine M, Fournier A, Vaudry H, Gonzalez BJ.
    J Neurosci Res; 2003 May 01; 72(3):303-16. PubMed ID: 12692897
    [Abstract] [Full Text] [Related]

  • 10. Balanced effect of PACAP and FasL on granule cell death during cerebellar development: a morphological, functional and behavioural characterization.
    Allais A, Burel D, Roy V, Arthaud S, Galas L, Isaac ER, Desfeux A, Parent B, Fournier A, Chapillon P, Sherwood NM, Vaudry H, Gonzalez BJ.
    J Neurochem; 2010 Apr 01; 113(2):329-40. PubMed ID: 20050979
    [Abstract] [Full Text] [Related]

  • 11. The neuropeptide pituitary adenylate cyclase activating protein stimulates human monocytes by transactivation of the Trk/NGF pathway.
    El Zein N, Badran BM, Sariban E.
    Cell Signal; 2007 Jan 01; 19(1):152-62. PubMed ID: 16914291
    [Abstract] [Full Text] [Related]

  • 12. Molecular, cellular, and functional characterizations of pituitary adenylate cyclase-activating polypeptide and its receptors in the cerebellum of New and Old World monkeys.
    Aubert N, Basille M, Falluel-Morel A, Vaudry D, Bucharles C, Jolivel V, Fisch C, De Jouffrey S, Le Bigot JF, Fournier A, Vaudry H, Gonzalez BJ.
    J Comp Neurol; 2007 Oct 01; 504(4):427-39. PubMed ID: 17663433
    [Abstract] [Full Text] [Related]

  • 13. Ontogeny of PACAP receptors in the human cerebellum: perspectives of therapeutic applications.
    Basille M, Falluel-Morel A, Vaudry D, Aubert N, Fournier A, Fréger P, Gallo-Payet N, Vaudry H, Gonzalez B.
    Regul Pept; 2006 Nov 15; 137(1-2):27-33. PubMed ID: 16963135
    [Abstract] [Full Text] [Related]

  • 14. Neurotrophic effects of PACAP in the cerebellar cortex.
    Botia B, Basille M, Allais A, Raoult E, Falluel-Morel A, Galas L, Jolivel V, Wurtz O, Komuro H, Fournier A, Vaudry H, Burel D, Gonzalez BJ, Vaudry D.
    Peptides; 2007 Sep 15; 28(9):1746-52. PubMed ID: 17544170
    [Abstract] [Full Text] [Related]

  • 15. Pituitary adenylate cyclase-activating polypeptide induces translocation of its G-protein-coupled receptor into caveolin-enriched membrane microdomains, leading to enhanced cyclic AMP generation and neurite outgrowth in PC12 cells.
    Zhang W, Duan W, Cheung NS, Huang Z, Shao K, Li QT.
    J Neurochem; 2007 Nov 15; 103(3):1157-67. PubMed ID: 17680996
    [Abstract] [Full Text] [Related]

  • 16. PACAP promotes sensory neuron differentiation: blockade by neurotrophic factors.
    Nielsen KM, Chaverra M, Hapner SJ, Nelson BR, Todd V, Zigmond RE, Lefcort F.
    Mol Cell Neurosci; 2004 Apr 15; 25(4):629-41. PubMed ID: 15080892
    [Abstract] [Full Text] [Related]

  • 17. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates the expression and the release of tissue plasminogen activator (tPA) in neuronal cells: involvement of tPA in the neuroprotective effect of PACAP.
    Raoult E, Roussel BD, Bénard M, Lefebvre T, Ravni A, Ali C, Vivien D, Komuro H, Fournier A, Vaudry H, Vaudry D, Galas L.
    J Neurochem; 2011 Dec 15; 119(5):920-31. PubMed ID: 21919910
    [Abstract] [Full Text] [Related]

  • 18. Differential expression of mRNAs for PACAP and its receptors during neural differentiation of embryonic stem cells.
    Hirose M, Hashimoto H, Shintani N, Nakanishi M, Arakawa N, Iga J, Niwa H, Miyazaki J, Baba A.
    Regul Pept; 2005 Mar 15; 126(1-2):109-13. PubMed ID: 15620423
    [Abstract] [Full Text] [Related]

  • 19. Somatostatin and pituitary adenylate cyclase-activating polypeptide (PACAP): two neuropeptides potentially involved in the development of the rat cerebellum.
    Gonzalez BJ, Leroux P, Basille M, Bodenant C, Vaudry H.
    Ann Endocrinol (Paris); 1994 Mar 15; 55(6):243-7. PubMed ID: 7864580
    [Abstract] [Full Text] [Related]

  • 20. Localization, characterization and function of pituitary adenylate cyclase-activating polypeptide during brain development.
    Watanabe J, Nakamachi T, Matsuno R, Hayashi D, Nakamura M, Kikuyama S, Nakajo S, Shioda S.
    Peptides; 2007 Sep 15; 28(9):1713-9. PubMed ID: 17719696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.